Abstract. Aberrant DNA hypermethylation is an important mechanism for the inactivation of tumor-related genes in human tumors. Gastric mucosa-associated lymphoid tissue (MALT) lymphomas arise from Helicobacter pylori-associated chronic gastritis; most patients are H. pylori-positive and eradication therapy is highly effective. In the present study, we used methylation-specific PCR to analyze the DNA methylation status of 11 tumor-related genes (Kip2, p16, p15, p73, MGMT, DAPK, MINT1, MINT2, MINT31 and HCAD) in 21 specimens of MALT lymphoma, 5 specimens of MALT lymphoma with large cell component (high-grade MALT lymphoma), 15 specimens of diffuse large B-cell lymphoma (DLBCL), 8 specimens of complete remission of MALT lymphoma after eradication therapy, 5 specimens with no evidence of malignancy and PBMCs from 10 healthy donors. The average number of methylated genes was significantly greater in gastric lymphomas as compared to normal controls (P<0.001). The CpG island methylator phenotype (CIMP) was observed in 93.3% (14/15) of DLBCLs, 100% (5/5) of high-grade MALT lymphomas and 61.9% (13/21) of MALT lymphomas; in contrast, CIMP was not found in the control group (0%). The average number of methylated genes and the CIMP incidence significantly increased with H. pylori infection. Furthermore, aberrant CpG methylation of specific genes, such as p16, MGMT and MINT31, was consistently associated with H. pylori infection. These findings strongly suggest that H. pylori infection causes the aberrant DNA hypermethylation of specific genes and induces CIMP, which is an important epigenetic mechanism for the development and progression of gastric MALT lymphoma; additionally, our findings provide new epigenetic markers.
Introduction
Mucosa-associated lymphoid tissue (MALT) lymphoma, a common low-grade B-cell lymphoma arising from a background of chronic inflammatory diseases at a number of mucosal sites, was first described by Isaacson and Wright in 1983 (1) . MALT lymphomas originating in the stomach are causatively linked to Helicobacter pylori infection and eradication of the bacterium with antibiotics leads to longterm complete remission of the lymphoma in ~70% of patients (2) . Additional evidence links Campylobacter jejuni (3) , Chlamydia psittaci (4), Borrelia burgdorferi (5) and hepatitis C virus (6, 7) infection with MALT lymphoma of the small intestine, ocular adnexa, skin and splenic marginal zone, respectively. These organs are normally devoid of organized lymphoid tissue and lymphoma. MALT lymphomas arise from these sites as a result of chronic inflammatory or autoimmune disorders, such as H. pylori-associated chronic gastritis, lymphoepithelial sialoadenitis, Sjögren syndrome and Hashimoto thyroiditis (8, 9) . The common karyotypic alterations that characterize MALT lymphoma include the trisomies of 3 and 18 (10, 11) and the translocations t(11;18) (q21;q21) (12, 13) , t(1;14)(p22;q32) (14, 15) , t(14;18)(q32;q21) (10, 16) , and t(3;14)(p14.1;q32) (17, 18) , which commonly activate the NF-κB pathway. The most common translocation is t(11;18) (q21;q21), which results from the fusion of the API2 (apoptosis inhibitor 2) and the MALT1 (MALT lymphomaassociated translocation) genes (19, 20) . Clonal identities of the immunoglobulin heavy chains between low-grade MALT lymphomas and coexisting diffuse large B-cell lymphoma (DLBCL) have been found in a considerable number of INTERNATIONAL JOURNAL OF ONCOLOGY 35: 547-557, 2009 547
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Helicobacter pylori infection promotes development and progression of gastric MALT lymphoma patients, indicating that low-grade MALT lymphoma progresses to high-grade malignancy composed of largesized lymphoma (DLBCL) (21, 22) . The detailed molecular mechanism of the progression to high-grade lymphoma has not been elucidated. Genetic abnormalities found in various cancers do not provide the complete picture of molecular mechanism of cancers and malignancies. Epigenetic changes, mainly DNA methylation and histone modification, are additional mechanisms that contribute to the malignant phenotype (23) (24) (25) . DNA methylation is a normal process used by mammalian cells in maintaining a normal expression pattern; it is involved in the regulation of imprinted gene expression and X-chromosome inactivation and in the fine-tuning of specific differentiation of cells and the development from stem cells (26) (27) (28) (29) . However, aberrant promoter hypermethylation of the CpG islands leads to epigenetic silencing of multiple genes, including tumor suppressor genes and has been recognized as an important mechanism in carcinogenesis (30) (31) (32) . Furthermore, concordant promoter hypermethylation of multiple genes, the CpG island methylator phenotype (CIMP), has been found in gastric and colorectal carcinomas (33) (34) (35) .
Our goal in the current study was to clarify the contribution of epigenetic abnormalities to disease development and progression. We comparatively evaluated the methylation status of 11 genes in gastric lymphomas and related diseases (MALT lymphoma, high-grade MALT lymphoma and DLBCL) and a control group that included complete remission specimens of MALT lymphoma after eradication therapy, specimens of no evidence of malignancy in the stomach and healthy donor peripheral blood mononuclear cells (PBMCs). In addition, we addressed the questions of whether CIMP is associated with gastric lymphoma development and/or progression.
Materials and methods
Specimens. Specimens were pathologically diagnosed at Okayama University Medical School from 1989 to 2000; there were 21 specimens of primary gastric MALT lymphoma (low-grade MALT lymphoma; L-MALT), 5 specimens of gastric MALT lymphoma with large cell component (highgrade MALT lymphoma; H-MALT) and 15 specimens of gastric DLBCL. The control group contained specimens from: 8 patients of complete remission (CR) of gastric MALT lymphoma after eradication therapy; 5 patients of no evidence of malignancy (NEM) in the stomach with infiltration of mononuclear cells, including chronic gastritis and 10 healthy donors of PBMCs. Informed consent was obtained from all patients and healthy volunteers. All the patient-derived materials in the present study were used following the guideline of Japanese Society of Pathology. All tissue samples were obtained by endoscopic biopsy with surgical resection followed by immediate freezing and storing at -80˚C. High molecular weight DNA was extracted by the phenol/chloroform method.
Sodium bisulfite modification and methylation-specific PCR (MSP)
. Sodium bisulfite modification of DNA was performed, as previously described (31, 32) . Briefly, 1 μg aliquots of genomic DNA were denatured by NaOH and modified by sodium bisulfite, which converts all unmethylated cytosines to uracils while leaving methylated cytosines unaltered. Modified DNA was purified, desulfonated with NaOH, precipitated with ethanol and resuspended in TE buffer. The methylation-specific PCR was performed to examine the methylation status of 11 tumor-related genes: cell-cycle regulators (Kip2, p16, p15) (36, 37) , mismatch repair (MGMT) (38) , DNA repair (hMLH-1) (39), tumor suppressor (p73) (40) , apoptosis (DAPK) (41) , cell adhesion [HCAD (CDH13)] (42) and methylated in tumor (MINT1, MINT2, MINT31) (33, 34) genes. CpGenome universal methylated DNA (Chemicon International Inc., Temecula, CA) was used as the methylationpositive control and PBMCs from healthy volunteers were used as negative controls. PCR products were electrophoresed on a 2% agarose gel, stained with ethidium bromide and visualized with a UV illuminator.
Evaluation of H. pylori infection. H. pylori infection status was
analyzed by PCR methods. The PCR conditions and primer sets have been described previously (43) . The primer sequence is listed in Table I . H. pylori genomic DNA (ATCC43504) was used as a positive control.
Statistical analysis. Statistical analysis was performed by using the Welch's t-test and two-tailed Fisher's exact test. SPSS software (version 11.5J, Chicago, IL) was used to perform the analysis.
Results
Methylation status of gastric MALT lymphoma and related diseases. Initially, we examined whether the aberrant DNA methylation in gastric lymphomas could be detected by MSP. CpG island methylation was analyzed in the promoter region of 11 tumor-related genes (p15, p16, kip2, p73, DAPK, hMLH-1, MGMT, HCAD, MINT1, MINT2 and MINT31) in gastric lymphoma specimens (15 DLBCLs, 21 L-MALT lymphomas and 5 H-MALT lymphomas) and also nonlymphoma controls (8 specimens of CR after eradication therapy; 5 specimens of NEM in the stomach, including chronic gastritis; and PBMCs from 10 healthy volunteers).
Representative results of MSP are shown in Fig. 1 . CpGenome was used as the MSP-positive control. DNA methylation was categorized in 5 groups (-, ±, +, ++ and +++) according to the signal intensity; '-' is no methylation signal; '±', very faint signal; + to +++, evident signal with different strengths. Only the categories from + to +++ were regarded as methylation-positive. Table II shows a clear difference in the methylation frequencies between the lymphoma and control groups.
The number of methylated genes shifted from low to high values according to the disease progression from healthy controls to L-MALT lymphoma and H-MALT lymphoma and DLBCL ( Fig. 2A) . The average number of methylated genes in each group is: healthy PBMCs, 0.4; NEM, 0.4; CR after eradication therapy, 1.4; H. pylori (-) L-MALT lymphoma, 3.5; H. pylori (+) L-MALT lymphoma, 5.5; H-MALT lymphoma, 7.8; and DLBCL, 6.4 (Fig. 2B ). The number of methylated genes was significantly greater in the lymphoma group compared to the control group (P<0.001, Kruskal-Wallis exact test). Interestingly, the frequency of methylated genes in CR patients after eradication therapy remarkably decreased, suggesting that aberrant DNA methylation was closely associated with the H. pylori infection. Table I . Primer sequences and PCR conditions for MSP analysis.
Primer sequences (5'-3') forward Primer sequences (5'-3') reverse of cycles)
U, unmethylated sequences and M, methylated sequences. An analysis of the differences in methylation frequency of the 11 genes among various stages of gastric MALT lymphomas and related diseases revealed a statistically significant difference in the DNA methylation incidence between the lymphoma and control groups, especially in the Kip2, p16, DAPK, MGMT, MINT1, MINT2 and MINT31 genes Results of MSP were shown as -, -/+, +, ++, or +++ according to the signal intensity. DLBCL, diffuse large B-cell lymphoma; H-MALT, highgrade MALT lymphoma; MALT, MALT lymphoma; CR, complete remission of MALT lymphoma; NEM, no evidence of malignancy in stomach; PBMCs, healthy donor peripheral blood mononuclear cells. The number of methylated genes was shown in the right-end column. CIMP (+) was defined as more than or equal to 4 genes were methylated. Hp, H. pylori infection. nd: not done. ( Table III) , suggesting that aberrant CpG methylation of particular genes was closely associated with the lymphomagenesis in the stage-specific manner.
CIMP in gastric lymphoma. An examination of the number of methylated genes among gastric lymphomas and controls revealed a clear boundary (between 3 and 4 methylated genes) in the distribution of the number of methylated genes (Fig. 3A) . All specimens with ≥4 methylated genes belong to the lymphoma group. On the other hand, almost all of the specimens with <4 methylated genes were in the control group. Therefore, we defined the CIMP-positive specimens as those specimens with at least 4 methylated genes. Specimens with <4 methylated genes were CIMP-negative. The CIMP (+) or (-) status in the lymphoma and control groups is summarized in Fig. 3B , indicating that 93.3% (14 of 15) of DLBCL, 100% (5 of 5) of H-MALT lymphoma and 61.9% (13 of 21) of L-MALT lymphoma were CIMP-positive. Contrary, all specimens of CR (8 of 8), NEM (5 of 5) and healthy PBMCs (10 of 10) were CIMP-negative. The incidence of CIMP (+) specimens was significantly higher in the lymphoma group than in the control group (P<0.001, two-tailed Fisher's exact test). CIMP-positive specimens increased according to the disease progression from L-MALT lymphoma to H-MALT lymphoma and to DLBCL.
Next, we analyzed the correlation between CIMP status and the methylation of each gene (Table IV) . Methylation of all genes except for the hMLH1 gene was correlated with CIMP status (P<0.004, Fisher's exact test). There was a statistically significant difference in the incidence of CIMP between the two stages of MALT lymphoma and related diseases, such as between healthy PBMCs and L-MALT (P=0.001); healthy PBMCs and H-MALT (P=0.000); healthy PBMCs and DLBCL (P=0.000); and NEM and H-MALT 
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a Fisher's exact test. Hp (+), H. pylori (+) MALT lymphoma with/without large cell compornent and DLBCL; Hp (-), H. pylori (-) MALT lymphoma with/without large cell compornent and DLBCL; NEM, no evidence for malignancy; low MALT, MALT lymphoma; high MALT, MALT lymphoma with large cell compornent. Bold numbers indicate significant differences of methylation frequency (P<0.05).
-- --------------------------------------------------------------------------------------------------- (P=0.008) (Table V), indicating that the incidence of CIMP in each lymphoma group was significantly higher than that of the control group.
Effects of H. pylori infection on the number of methylated genes and CIMP. We analyzed the effects of H. Pylori
infection on the number of methylated genes and CIMP status (Fig. 4) . The distribution of the number of methylated genes with or without H. pylori infection in MALT lymphoma indicates that the number of methylated genes was shifted to a higher value in cases of H. pylori infection (Fig. 4A) . The CIMP (+) incidence was significantly higher in H. Pylori (+) L-MALT (89%, 8/9) compared to H. Pylori (-) L-MALT (42%, 5/12) (P=0.037) (Fig. 4B) . H. Pylori (+) gastric lymphoma also showed significantly higher CIMP (+) incidence (93%, 27/29) than H. Pylori (-) gastric lymphoma (42%, 5/12)(P<0.001) (Fig. 4C) . Table VI On the other hand, the methylation frequency of these genes (except for the MINT2 gene) dramatically decreased in CR after eradication therapy compared to H. pylori (+) L-MALT Table IV . Correlation between presence of CIMP and methylation of each gene. 
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Fisher's exact test. Table V . Statistical difference in the incidence of CIMP among various stages of MALT lymphoma and related diseases.
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(P<0.05). These statistically significant alterations in the methylation frequency of the 11 genes among various clinical states, including MALT lymphoma with or without H. pylori infection and related diseases, are summarized in Fig. 5A and B.
Discussion
A close link between H. pylori infection and the development of gastric MALT lymphoma has been established by the detection of H. pylori infection in most patients of gastric MALT lymphoma (1, 2, 19, 20) . We previously reported that autoimmune reactions evoked by immunological crossreactivity between H. pylori HSP60 and host HSP60 are important in the development of gastric MALT lymphoma because of the molecular mimicry between human HSP60 and H. pylori HSP60 (44) (45) (46) (47) .
In the present study, we investigated the aberrant DNA hypermethylation in gastric lymphoma, including L-MALT lymphoma, H-MALT lymphoma and DLBCL, showing that Tables III and VI. the number of methylated genes is clearly greater in the lymphoma group as compared to the control group ( Fig. 2A  and B) . Furthermore, according to the progression from L-MALT to H-MALT and to DLBCL, the number of methylated genes shifted from low to high values, indicating that the aberrant hypermethylated genes accumulated in the course of disease progression. There was a significant difference in the incidence of CIMP between the lymphoma group and the control group (Fig. 3B) , suggesting that there are abnormalities in the regulatory and/or maintenance mechanism of DNA methylation status that cause aberrant hypermethylation to accumulate in specific genes in gastric lymphomas. Interestingly, a specific group of genes was targeted for aberrant hypermethylation in a stage-specific manner in gastric lymphoma progression and related diseases (Tables III and VI and Fig. 5A and B) . The group of genes, including Kip2, p16, DAPK, HCAD, MGMT, MINT2 and MINT31, was significantly hypermethylated during the onset of H. pylori (+) L-MALT from healthy PBMCs (Table V, Fig. 5A ). The same group of genes (except for the MINT2) was significantly de-methylated in the CR state post-eradication therapy from H. pylori (+) L-MALT (Table VI, Table VI , Fig. 5A ). Aberrant hypermethylation of MGMT was also closely associated with the progression from H. pylori (+) H-MALT to DLBCL (P=0.038, Table III , Fig. 5A ).
On the other hand, a small number of genes, including p16, Kip2, DAPK and HCAD, were associated with the onset of H. pylori (-) L-MALT from healthy PBMCs, suggesting that these genes contribute to the triggering of H. pylori (-) L-MALT independent of H. pylori infection (Table VI, Fig. 5B ). In the progression from H. pylori (-) L-MALT to H. pylori (+) H-MALT, another group of genes, such as p16, MGMT, 
Statistical differences of methylation frequency between two groups 
Fisher's exact test. Hp (+), H. pylori (+) MALT lymphoma with/without large cell compornent and DLBCL; Hp (-), H. pylori (-) MALT lymphoma with/without large cell compornent and DLBCL; NEM, no evidence for malignancy; low MALT, MALT lymphoma; high MALT, MALT lymphoma with large cell compornent. Bold numbers indicate significant differences of methylation frequency (P<0.05).
-----------------------------------------------------------------------------------------------------
MINT1, MINT2 and MINT31, were significantly hypermethylated (Table VI, Fig. 5B ). This process was associated with H. pylori infection, which was closely similar to the methylation profile alteration at the onset of H. pylori (+) L-MALT from healthy PBMC accompanied with the H. pylori infection. The aberrant hypermethylation of MINT1 was significantly associated with the progression from L-MALT to H-MALT and also to DLBCL (Table III, Fig. 5B) . Similarly, MGMT hypermethylation was significantly associated with the progression from H-MALT to DLBCL (Table III) , comparing the H. pylori (+) L-MALT process (Fig. 5A) with the H. pylori (-) L-MALT process (Fig. 5B) , it is clear that hypermethylation of specific target genes, such as p16, MGMT, MINT2 and MINT31, is closely associated with H. pylori infection. It suggests the possibility that H. pylori infection perturbs or alters the epigenetic status, including the methylation profile, with the production of H. pylorispecific molecules, such as CagA, VacA, OipA and DNA methyltransferase (hpy1M or hpyIIM) (48, 49) , cytokines or inflammatory responses with the production of reactive oxygen species to cause aberrant hypermethylation of specific genes, followed by malignant transformation events including aberrant hypermethylation of other genes, alteration of miRNA expression profile, histone modification and/or chromatin organization changes. Contact of H. pylori with the epithelium induces transcription of the induced-by-contact-withepithelium gene (iceA1); the presence of this gene product has been associated with duodenal ulceration and gastric adenocarcinoma (50) . The expression of H. pylori methyltransferase hpy1M accompanies iceA1 (48) . H. pylori DNA methyltransferases may be one candidate to cause aberrant hypermethylation in addition to host DNA methyltransferases. The effectiveness of H. pylori eradication therapy in H. pylori (+) L-MALT is consistent with the reversibility of epigenetic modifications and alterations (including DNA methylation) in response to micro-environmental conditions, nutrition and drugs.
Our findings strongly suggest that H. pylori infection causes the aberrant DNA hypermethylation of specific genes and induces CIMP, an important epigenetic mechanism of the development and progression of gastric MALT lymphoma. The genes that were specifically hypermethylated by the H. pylori infection and disease progression could be used as highly sensitive epigenetic markers to detect H. pylori infection and the development and progression of gastric lymphoma, as well as to monitor the disease status.
